Inventor · disambiguated record
Mark Newman
Also filed as: NEWMAN MARK · NEWMAN MARK J · NEWMAN MARK JOSEPH
12 granted patents·8 pending applications·158 citations·filing 1995–2015
92Inventor score
Top patents by PatentIndex Score
20 records- 0194US6416947B1Vaccine adjuvant and vaccine methodCYTRX CORP·Filed 2000·Granted Jul 9, 2002·45 cites·22 claims
- 0292US7888472B2Optimized multi-epitope constructs and uses thereofEPIMMUNE INC·Filed 2009·Granted Feb 15, 2011·12 cites·6 claims
- 0390US7462354B2Method and system for optimizing minigenes and peptides encoded therebyPHARMEXA INC·Filed 2001·Granted Dec 9, 2008·31 cites·20 claims
- 0478US7507803B2Optimized multi-epitope constructs and uses thereofGENIMMUNE N V·Filed 2003·Granted Mar 24, 2009·7 cites·4 claims
- 0578US6086899AVaccine adjuvant and vaccineCYTRX CORP·Filed 1995·Granted Jul 11, 2000·22 cites·16 claims
- 0676US9249187B2Pan-DR binding polypeptides and uses thereofDEGAN FLORENCE DAL·Filed 2010·Granted Feb 2, 2016·7 cites·13 claims
- 0776US6933286B2Therapeutic delivery compositions and methods of use thereofFiled 2001·Granted Aug 23, 2005·14 cites·26 claims
- 0864US6844001B2Adjuvants and copolymer compositionsCYT RX CORP·Filed 2002·Granted Jan 18, 2005·6 cites·13 claims
- 0962US7045576B2Adjuvants and copolymer compositionsCYTRX CORP·Filed 2004·Granted May 16, 2006·3 cites·6 claims
- 1061US6149922AVaccine adjuvant and vaccineCYTRX CORP·Filed 1998·Granted Nov 21, 2000·11 cites·5 claims
- 1161US2010099613A1Peptides for inducing a ctl and/or htl response to hepatitis c virusGENIMMUNE·Filed 2009·Application pending·0 cites
- 1260US2010049491A1Method and System for Optimizing Minigenes and Peptides Encoded TherebySETTE ALESSANDRO·Filed 2008·Application pending·0 cites
- 1358US2006093617A1Peptides for inducing a CTL and/or HTL response to hepatitis C virusEPIMMUNE INC·Filed 2005·Application pending·0 cites
- 1455US9789181B2PAN-DR binding polypeptides and uses thereofEPIMMUNE INC·Filed 2015·Granted Oct 17, 2017·0 cites·12 claims
- 1550US2007054262A1Methods of identifying optimal variants of peptide epitopesBAKER DENISE M·Filed 2004·Application pending·0 cites
- 1647US2007014810A1Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositionsBAKER DENISE·Filed 2005·Application pending·0 cites
- 1746US2004248113A1Method and system for optimizing multi-epitope nucleic acid constructs and peptides encoded therebyFiled 2002·Application pending·0 cites
- 1843US2009317412A1Induction of an immune response against streptococcus pneumoniae polyaccharidesALEXANDER JEFFERY L·Filed 2005·Application pending·0 cites
- 1942US9511134B2Inducing immune responses to influenza virus using polypeptide and nucleic acid compositionsALEXANDER JEFFERY L·Filed 2007·Granted Dec 6, 2016·0 cites·7 claims
- 2042US2004248833A1Therapeutic delivery compositions and methods of use thereofFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Newman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →